Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Controversies in prostate cancer screening.

Alana M Murphy1, James M McKiernan, Carl A Olsson

  • 1Department of Urology, Columbia University Medical Center, New York, New York 10032, USA.

The Journal of Urology
|November 16, 2004
PubMed
Summary

Prostate cancer screening is crucial for improving patient outcomes, despite criticisms. Continued support for screening is vital to reduce prostate cancer mortality rates and enhance prognosis.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Neoadjuvant Fc-enhanced anti-CTLA-4 targets Tregs to augment androgen deprivation in high-risk prostate cancer: A randomized phase I trial.

Cell reports. Medicine·2026
Same author

Treatment patterns for genitourinary syndrome of menopause: a TriNetX analysis.

The Canadian journal of urology·2026
Same author

Revisiting BCG: The potential of rescue BCG therapy for BCG-unresponsive non-muscle-invasive bladder cancer.

Urologic oncology·2025
Same author

Reply to Editorial Comment on "A Comparison of Preoperative Frailty Indices Correlation With Perioperative Risk for Patients Undergoing Sacrocolpopexy".

Urology·2025
Same author

Combination regimen of intravesical docetaxel, gemcitabine, and cisplatin in patients with BCG-unresponsive bladder cancer: clinical outcomes and genomic correlations.

Urologic oncology·2025
Same author

The Academic Relative Value Unit: How to Quantify and Reward Nonclinical Efforts?

Urology practice·2025

Area of Science:

  • Oncology
  • Urology
  • Public Health

Background:

  • Prostate cancer is a leading cause of cancer death in men.
  • Controversy exists regarding the efficacy and necessity of prostate cancer screening.
  • Criticisms include cost, biopsy morbidity, low predictive value, overtreatment, and lack of mortality benefit evidence.

Purpose of the Study:

  • To address and discuss the criticisms surrounding prostate cancer screening.
  • To highlight the importance of prostate cancer screening in managing the disease.
  • To advocate for continued support and implementation of prostate cancer screening programs.

Main Methods:

  • A comprehensive discussion was formulated to address criticisms of prostate cancer screening.
  • Concerns common to other widely accepted cancer screening programs were analyzed.
  • The potential dangers of abandoning prostate cancer screening were examined.

Main Results:

  • Concerns about cost, morbidity, and predictive value are shared with other accepted screening programs.
  • Abandoning prostate cancer screening poses significant risks, as indicated by watchful waiting and Markov modeling.
  • Prostate cancer screening in the US has led to stage migration and a decreased mortality rate.

Conclusions:

  • The prostate-specific antigen (PSA) era offers significant promise for improving prostate cancer prognosis.
  • Widespread prostate cancer screening is essential for better patient outcomes.
  • Continued support for prostate cancer screening initiatives is necessary.

Related Experiment Videos